Literatura académica sobre el tema "Leukaemia, Stem cells, Hypoxia, HIF"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Leukaemia, Stem cells, Hypoxia, HIF".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Leukaemia, Stem cells, Hypoxia, HIF"
Gezer, Deniz, Amelie V. Guitart, Milica Vukovic, Chithra Subramani, Karen Dunn, Patrick Pollard, Peter J. Ratcliffe, Tessa L. Holyoake y Kamil Kranc. "HIF-1α Is Not Essential For The Establishment Of MLL-Leukaemic Stem Cells". Blood 122, n.º 21 (15 de noviembre de 2013): 3767. http://dx.doi.org/10.1182/blood.v122.21.3767.3767.
Texto completoTomita, Mariko, Gregg L. Semenza, Canine Michiels, Takehiro Matsuda, Jun-Nosuke Uchihara, Taeko Okudaira, Yuetsu Tanaka, Naoya Taira, Kazuiku Ohshiro y Naoki Mori. "Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells". Biochemical Journal 406, n.º 2 (13 de agosto de 2007): 317–23. http://dx.doi.org/10.1042/bj20070286.
Texto completoChoi, Jong Ho, Yun Bin Lee, Jieun Jung, Seong Gyu Hwang, IL-Hoan Oh y Gi Jin Kim. "Hypoxia Inducible Factor-1αRegulates the Migration of Bone Marrow Mesenchymal Stem Cells via Integrinα4". Stem Cells International 2016 (2016): 1–11. http://dx.doi.org/10.1155/2016/7932185.
Texto completoBernard, Olivier, Florence Jeny, Yurdagül Uzunhan, Elisabetta Dondi, Rahma Terfous, Rabab Label, Angela Sutton et al. "Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating HIF and ROS hypoxic signaling". American Journal of Physiology-Lung Cellular and Molecular Physiology 314, n.º 3 (1 de marzo de 2018): L360—L371. http://dx.doi.org/10.1152/ajplung.00153.2017.
Texto completoEliasson, Pernilla M. y Jan-Ingvar Jönsson. "A Hypoxic Niche in the Mouse Bone Marrow Diminishes Proliferation and Differentiation of Hematopoietic Stem Cells". Blood 112, n.º 11 (16 de noviembre de 2008): 4777. http://dx.doi.org/10.1182/blood.v112.11.4777.4777.
Texto completoHu, Cheng-Jun, Sangeeta Iyer, Aneesa Sataur, Kelly L. Covello, Lewis A. Chodosh y M. Celeste Simon. "Differential Regulation of the Transcriptional Activities of Hypoxia-Inducible Factor 1 Alpha (HIF-1α) and HIF-2α in Stem Cells". Molecular and Cellular Biology 26, n.º 9 (1 de mayo de 2006): 3514–26. http://dx.doi.org/10.1128/mcb.26.9.3514-3526.2006.
Texto completoTang, Di, Junhui Zhang, Tiantian Yan, Jingyu Wei, Xupin Jiang, Dongxia Zhang, Qiong Zhang, Jiezhi Jia y Yuesheng Huang. "FG-4592 Accelerates Cutaneous Wound Healing by Epidermal Stem Cell Activation via HIF-1α Stabilization". Cellular Physiology and Biochemistry 46, n.º 6 (2018): 2460–70. http://dx.doi.org/10.1159/000489652.
Texto completoChang, Yao-Lung, Shuenn-Dyh Chang, An-Shine Chao, Martin Sieber, Chia-Lung Tsai y Po-Jen Cheng. "Effect of Hypoxia on Glucose Transporter 1 and 3 Gene Expression in Placental Mesenchymal Stem Cells Derived from Growth-Restricted Fetuses". Genes 13, n.º 5 (25 de abril de 2022): 752. http://dx.doi.org/10.3390/genes13050752.
Texto completoChang, Yao-Lung, Shuenn-Dyh Chang, An-Shine Chao, Martin Sieber, Chia-Lung Tsai y Po-Jen Cheng. "Effect of Hypoxia on Glucose Transporter 1 and 3 Gene Expression in Placental Mesenchymal Stem Cells Derived from Growth-Restricted Fetuses". Genes 13, n.º 5 (25 de abril de 2022): 752. http://dx.doi.org/10.3390/genes13050752.
Texto completoCarcelén, María, Carlos Velásquez, Veronica Vidal, Olga Gutierrez y Jose L. Fernandez-Luna. "HIF2α Upregulates the Migration Factor ODZ1 under Hypoxia in Glioblastoma Stem Cells". International Journal of Molecular Sciences 23, n.º 2 (11 de enero de 2022): 741. http://dx.doi.org/10.3390/ijms23020741.
Texto completoTesis sobre el tema "Leukaemia, Stem cells, Hypoxia, HIF"
Cochran, David M. Ph D. Massachusetts Institute of Technology. "The role of HIF-1 alpha in the localization of embryonic stem cells with respect to hypoxia within teratomas". Thesis, Massachusetts Institute of Technology, 2005. http://hdl.handle.net/1721.1/33841.
Texto completoIncludes bibliographical references (leaves 172-183).
In embryonic stem (ES) cell tumors, the hypoxia-inducible transcription factor, HIF- 1[alpha], has been shown to be a tumor suppressor, and HIF-1[alpha]-expressing cells have been shown to localize preferentially in vivo to regions near tumor vasculature. These differences were proposed to be due to increased hypoxia-induced apoptosis and growth arrest of HIF-1[alpha]-expressing ES cells. This thesis presents a careful investigation into the localization of ES cells in vitro and in vivo with respect to hypoxia. A sandwich culture system was utilized in which controlled gradients of oxygen and nutrients are developed in the vicinity of the tumor cells. A diffusion-consumption model was utilized to predict the oxygen and glucose concentration profiles within the system. Oxygen and glucose consumption rates were measured and used as inputs into the model, and the concentration profiles were found to depend on a single experimental parameter, the cell density within the system. The optimum cell density was found in which stable, measurable oxygen gradients develop over 2-3 mm. The model demonstrated excellent agreement between the predicted oxygen concentration profiles and experimentally determined oxygen gradients. In vitro, there was no difference in localization with respect to hypoxia between tumor cells expressing or lacking HIF-1[alpha].
(cont.) In addition, there was no difference in apoptosis, proliferation, or migration of the tumor cells in vitro based on HIF-1[alpha] expression. Likewise, a quantitative study on localization of tumor cells within tumors in vivo demonstrated no difference between localization of HIF-1[alpha]-expressing vs. HIF-1[alpha]-lacking ES cells within tumors with respect to blood vessels or hypoxia. These results differ from previous studies, perhaps due to clonal variation of the cell phenotype or the interplay of other complex environmental factors that were not considered in this study. Interestingly, the HIF-1[alpha]-lacking cells were found to exhibit increased tumor growth relative to the HIF-1[alpha]-expressing cells, perhaps due to a normalization of the blood vessels within the HIF-1[alpha]-lacking tumors. These studies reveal the complex role of HIF-1[alpha] in tumor growth and tumor cell localization, as well as develop a useful quantitative experimental model for studying the role of the microenvironment in tumors or in embryonic stem cell biology.
by David M. Cochran.
Ph.D.
Krieg, Marie-Louise. "Impact of Oxygen-Release Material on Human Urine-Derived Stem Cells’ Differentiation and Proliferation in Hypoxic Condition In Vitro". Thesis, Uppsala universitet, Tillämpad materialvetenskap, 2010. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-126039.
Texto completoWozny, Anne-sophie. "Mécanismes moléculaires spécifiques de la réponse aux ions carbone dans les cellules tumorales (souches et non souches) des cancers des Voies Aéro-Digestives Supérieures". Thesis, Lyon, 2018. https://n2t.net/ark:/47881/m6m044rb.
Texto completoHadrontherapy using carbon ions is an alternative to photon irradiation in the treatment of Head and Neck cancers, because of accurate ballistics and high biological efficiency, including hypoxic tumor areas. These cancers are of poor prognosis because of a high risk of recurrences related to the presence of cancer stem cells (CSCs).The aim of this work was to determine the molecular specificities of the response to carbon ion irradiations compared to photons in two cancer cell lines and their CSCs’ subpopulation, in hypoxic and normoxic conditions. This work focused on the role of the HIF-1α protein in cell survival, since hypoxia promotes its stabilization, but also in the radioresistance; the epithelial-mesenchymal transition (EMT) and the detection and repair of DNA double-strand breaks (DSBs). HIF-1α is stabilized earlier in CSCs compared to non-CSCs. Its activation, as well as the EMT pathways (STAT3, MEK/p38/JNK and Akt/mTOR), are dependent on reactive oxygen species (ROS), whose production is homogeneous in response to photons. At the opposite, the ROS produced in the carbon ion tracks are insufficient to activate HIF-1α and the upstream EMT pathways. Under hypoxic conditions, a relationship has been established between HIF-1α activation and that of the DSBs detection (ATM) and repair (Rad51) pathways (Homologous Recombination). These studies demonstrate that the therapeutic advantage of carbon ions is based on the spatial ROS distribution at the nanoscale and consequently on the non-activation of key pathways involved in tumor cell defense
CHELONI, GIULIA. "Chronic myeloid leukaemia stem cells are sensitive to the pharmacological inhibition of hypoxia inducible factor-1a". Doctoral thesis, 2015. http://hdl.handle.net/2158/1042876.
Texto completoLi, Zhizhong. "Differential Angiogenic Capability and Hypoxia Responses in Glioma Stem Cells". Diss., 2009. http://hdl.handle.net/10161/1149.
Texto completoMalignant gliomas are highly lethal cancers characterized by florid angiogenesis. Glioma stem cells (GSCs), enriched through CD133 (Prominin1) selection, are highly tumorigenic and therapy resistance. However, the mechanism through which GSCs promote tumor growth was largely unknown. As we noticed that tumors derived from GSCs contain widespread tumor angiogenesis, necrosis, and hemorrhage, we examined thepotential of GSCs to support tumor angiogenesis. We measured the expression of a panel of angiogenic factors secreted by GSCs. In comparison with matched non-GSC populations, GSCs consistently secreted markedly elevated levels of vascular endothelial growth factor (VEGF), which were further induced by hypoxia. In an in vitro model of angiogenesis, GSC-conditioned medium significantly increased endothelial cell migration and tube formation compared with non-GSC glioma cell-conditioned medium. The proangiogenic effects of GSCs on endothelial cells were specifically abolished by the anti-VEGF neutralizing antibody bevacizumab, which is in clinical use for cancer therapy. Furthermore, bevacizumab displayed potent antiangiogenic efficacy in vivo and suppressed growth of xenografts derived from GSCs but limited efficacy against xenografts derived from a matched non-GSC population. As hypoxia is a key regulator of angiogenesis, I further examined hypoxic responses in GSCs to determine the molecular mechanisms underlying their angiogenic drive. I demonstrated that multiple hypoxia response genes, including the hypoxia-inducible factors (HIFs)-1a and -2a(EPAS-1) were differentially expressed in GSCs in comparison to non-stem glioma cells and normal neural progenitors. GSCs preferentially induced HIF2a; and HIF2a-regulated genes under hypoxia in comparison to non-stem glioma cells. In contrast, neural progenitor/stem cells did not induce HIF2a in response to hypoxia suggesting that the HIF2a hypoxic response is not a general stem cell response. Targeting HIF1a or HIF2a in GSCs using short hairpin RNA (shRNA) inhibited neurosphere formation efficiency, indicating a requirement for HIFs in cancer stem cell self-renewal. HIF1a and HIF2a were also necessary for VEGF expression in GSCs, but HIF2a was not required in matched non-stem glioma cells. In vivo experiments determined that knockdown of HIFs significantly attenuated the tumorigenic capacity of GSCs and increased survival of immunocompromised mice. Together, our work provides the first evidence that that GSCs can be a crucial source of key angiogenic factors in cancers due to their differential hypoxia responses. It also suggests that anti-angiogenic therapies can be designed to target GSC-specific molecular mechanisms of neoangiogenesis, including the expression and/or activity of HIF2a.
Dissertation
TANTURLI, MICHELE. "Ruolo dell'adattamento all'ipossia di cellule di leucemia mieloide cronica nella loro resistenza al trattamento". Doctoral thesis, 2011. http://hdl.handle.net/2158/997010.
Texto completoWozny, Anne-Sophie. "Mécanismes moléculaires spécifiques de la réponse aux ions carbone dans les cellules tumorales (souches et non souches) des cancers des Voies Aéro-Digestives Supérieures". Thesis, 2018. http://www.theses.fr/2018LYSE1120.
Texto completoHadrontherapy using carbon ions is an alternative to photon irradiation in the treatment of Head and Neck cancers, because of accurate ballistics and high biological efficiency, including hypoxic tumor areas. These cancers are of poor prognosis because of a high risk of recurrences related to the presence of cancer stem cells (CSCs).The aim of this work was to determine the molecular specificities of the response to carbon ion irradiations compared to photons in two cancer cell lines and their CSCs’ subpopulation, in hypoxic and normoxic conditions. This work focused on the role of the HIF-1α protein in cell survival, since hypoxia promotes its stabilization, but also in the radioresistance; the epithelial-mesenchymal transition (EMT) and the detection and repair of DNA double-strand breaks (DSBs). HIF-1α is stabilized earlier in CSCs compared to non-CSCs. Its activation, as well as the EMT pathways (STAT3, MEK/p38/JNK and Akt/mTOR), are dependent on reactive oxygen species (ROS), whose production is homogeneous in response to photons. At the opposite, the ROS produced in the carbon ion tracks are insufficient to activate HIF-1α and the upstream EMT pathways. Under hypoxic conditions, a relationship has been established between HIF-1α activation and that of the DSBs detection (ATM) and repair (Rad51) pathways (Homologous Recombination). These studies demonstrate that the therapeutic advantage of carbon ions is based on the spatial ROS distribution at the nanoscale and consequently on the non-activation of key pathways involved in tumor cell defense
Capítulos de libros sobre el tema "Leukaemia, Stem cells, Hypoxia, HIF"
Ude, Arinzechukwu y Kelechi Okeke. "Leukaemia: The Purinergic System and Small Extracellular Vesicles". En Purinergic System [Working Title]. IntechOpen, 2022. http://dx.doi.org/10.5772/intechopen.104326.
Texto completo